2 recruiting, 1 not yet recruiting. 2 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Squamous Cell Carcinoma (Skin): new trials by email Literature Review of Squamous Cell Carcinoma (Skin) trials Research Report on Squamous Cell Carcinoma (Skin)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hair Regrowth Following Partial Thickness Removal of SSCIS Partial Thickness Excision - Squamous Cell Carcinoma (Skin), Squamous Cell Carcinoma in Situ | Not applicable | Not yet recruiting | The Cooper Health System | 15 | 2026-09-01 | 2026-09-09 |
| Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies Two photon microscopy imaging - Basal Cell Carcinoma of Skin, Squamous Cell Carcinoma (Skin) | Not applicable | Recruiting | University of Rochester | 92 | 2026-06-24 | 2026-08-19 |
| A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors AZD6750, rilvegostomig - Melanoma, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Recruiting | AstraZeneca | 120 | 2025-07-29 | 2026-10-08 |
Carcinoma, Squamous Cell (3) · Alopecia (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Melanoma (1) · Squamous Cell Carcinoma of Head and Neck (1) · Squamous Intraepithelial Lesions (1) · Stomach Neoplasms (1) · Triple Negative Breast Neoplasms (1)
Carcinoma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Neoplasms, Squamous Cell (3) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Adenocarcinoma (1) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Neuroendocrine (1) · DNA Virus Infections (1) · Digestive System Diseases (1)
AstraZeneca (1) · The Cooper Health System (1) · University of Rochester (1)
United States (2) · Australia (1) · Japan (1) · South Korea (1)
R37CA258376 (1)